Borghi Claudio, Fogacci Federica, Agnoletti Davide, Cicero Arrigo F G
Medical and Surgical Sciences Department, Hypertension and Cardiovascular Risk Factors Research Center, Sant'Orsola-Malpighi University Hospital, U.O. Medicina Interna Cardiovascolare, Alma Mater Studiorum University of Bologna, Via Albertoni, 15, 40138, Bologna, Italy.
IRCCS AOU S. Orsola-Malpighi, Bologna, Italy.
High Blood Press Cardiovasc Prev. 2022 May;29(3):221-230. doi: 10.1007/s40292-022-00507-8. Epub 2022 Mar 25.
Treating blood pressure (BP) alone may provide only limited benefits while it is recommendable to manage the total cardiovascular risk. To date, several studies have shown that concomitant treatment of hypertension and dyslipidemia with non-pharmacological approaches and/or metabolically neutral antihypertensive drugs and statins produce a significantly greater reduction of the risk of developing cardiovascular disease. Thus, in this review article, we summarize the available evidence regarding non-pharmacological and pharmacological approaches with a favourable effect on both BP and lipids.
单独治疗血压可能仅带来有限的益处，而建议对心血管疾病总体风险进行管理。迄今为止，多项研究表明，采用非药物方法和/或代谢中性的抗高血压药物及他汀类药物联合治疗高血压和血脂异常，可显著降低发生心血管疾病的风险。因此，在这篇综述文章中，我们总结了有关对血压和血脂均有有利影响的非药物和药物治疗方法的现有证据。
